CLINICAL_TRIALS
trial_result
· 2020-11-19
Clinical Trial Update: Dose-finding Study of GLPG0634 as Monotherapy in Active Rheumatoid Arthritis (RA) Participants (DARWIN2) [Phase 2]
Summary
Phase 2 dose-finding study of GLPG0634 as monotherapy in active rheumatoid arthritis completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Galapagos NV | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED | Results posted: 2020-11-19